St. Jude ICD, CRT-D Recall Addresses Battery Problems and Cybersecurity Risks
The FDA has approved a new update to address battery problems linked to Abbott Laboratories (formerly St. Jude) ICD and CRT-D heart implants.…
«
»
The FDA has approved a new update to address battery problems linked to Abbott Laboratories (formerly St. Jude) ICD and CRT-D heart implants.…
The federal judge overseeing all testosterone lawsuit has ordered parties to prepare 82 cases for trial over the next two years.…
Two additional testosterone trials are scheduled to begin in January as the pace of the bellwether program begins to ramp up over claims of heart attacks, deep vein thrombosis and pulmonary embolism injuries.…
A settlement status conference for AndroGel litigation is scheduled for November 2 following two massive verdicts against the manufacturer involve claims that the testosterone gel causes heart attacks and strokes.…
The FDA has announced that St. Jude has released new software meant to provide earlier warning of possible battery failure in recalled defibrillator implants.…
A Depakote birth defect lawsuit accuses Abbott Laboratories and AbbVie of failing to warn pregnant mothers and the medical community of the risk of malformations and cognitive defects associated with the epilepsy drug.…
A class action lawsuit against St. Jude and Abbott Laboratories accuses the companies of knowingly selling defective defibrillators with batteries that could rapidly fail, costing insurers millions of dollars.…
A Depakote lawsuit has ended in a $15 million verdict for a mother and son who blame the boy’s split spine on the epilepsy drug’s side effects.…
About 29,000 HeartMate II LVAS pocket controllers are subject of an FDA recall warning following the death of 26 patients who tried changing the controller improperly or too slowly.…
Hundreds of thousands of Abbott coronary catheters have been recalled over problems with a protective balloon sheath that have been linked to at least one patient death.…